Paclitaxel treatment of ovarian tumor SKOV-3 cells at the sublethal dose in culture renders them more susceptible to lymphokine-activated killer cytolysis

Kim-Sheng Law; Shuen-Kuei Liao

Paclitaxel treatment of ovarian tumor SKOV-3 cells at the sublethal dose in culture renders them more susceptible to lymphokine-activated killer cytolysis

Kim-Sheng Law
, Shuen-Kuei Liao

臨床醫學研究所(含碩博士班)

研究成果: 期刊稿件 › 文章 › 同行評審

原文	美式英語
期刊	Cancer Research
卷	66
發行號	8
出版狀態	已出版 - 2006

引用此

@article{dbe9b6d6d45a4790a2314f4678892357,

title = "Paclitaxel treatment of ovarian tumor SKOV-3 cells at the sublethal dose in culture renders them more susceptible to lymphokine-activated killer cytolysis",

author = "Kim-Sheng Law and Shuen-Kuei Liao",

year = "2006",

language = "American English",

volume = "66",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "8",

}